These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 3840854)

  • 1. Treatment of Graves' ophthalmopathy with cyclosporin A.
    Witte A; Landgraf R; Markl A; Boergen KP; Hasenfratz G; Pickardt CR
    Klin Wochenschr; 1985 Oct; 63(19):1000-4. PubMed ID: 3840854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin improves Graves' ophthalmopathy.
    Weetman AP; McGregor AM; Ludgate M; Beck L; Mills PV; Lazarus JH; Hall R
    Lancet; 1983 Aug; 2(8348):486-9. PubMed ID: 6136647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
    Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
    Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orbital scintigraphy with [111In-diethylenetriamine pentaacetic acid-D-phe1]-octreotide predicts the clinical response to corticosteroid therapy in patients with Graves' ophthalmopathy.
    Colao A; Lastoria S; Ferone D; Pivonello R; Macchia PE; Vassallo P; Bonavolonta G; Muto P; Lombardi G; Fenzi G
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3790-4. PubMed ID: 9814448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of severe Graves' ophthalmopathy with cyclosporin A.
    Utech C; Wulle KG; Bieler EU; Pfannenstiel P; Panitz N; Kiefer H
    Acta Endocrinol (Copenh); 1985 Dec; 110(4):493-8. PubMed ID: 3911714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative CT of the orbit in Graves' disease.
    Ozgen A; Alp MN; Ariyürek M; Tütüncü NB; Can I; Günalp I
    Br J Radiol; 1999 Aug; 72(860):757-62. PubMed ID: 10624341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
    Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
    Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Graves' ophthalmopathy with cyclosporin A.
    Kvetny J; Frandsen NE; Johnsen T; Dieperinck H; Mogensen E
    Acta Med Scand; 1986; 220(2):189-91. PubMed ID: 3535393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of steroid pulse therapy with and without orbital radiotherapy on Graves' ophthalmopathy.
    Ohtsuka K; Sato A; Kawaguchi S; Hashimoto M; Suzuki Y
    Am J Ophthalmol; 2003 Mar; 135(3):285-90. PubMed ID: 12614743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study.
    Kahaly G; Schrezenmeir J; Krause U; Schweikert B; Meuer S; Muller W; Dennebaum R; Beyer J
    Eur J Clin Invest; 1986 Oct; 16(5):415-22. PubMed ID: 3100309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed tomography in Graves' ophthalmopathy.
    Enzmann D; Marshal WH; Rosenthal AR; Kriss JP
    Radiology; 1976 Mar; 118(3):615-20. PubMed ID: 946330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy.
    Prummel MF; Mourits MP; Berghout A; Krenning EP; van der Gaag R; Koornneef L; Wiersinga WM
    N Engl J Med; 1989 Nov; 321(20):1353-9. PubMed ID: 2519530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deterioration of severe Graves' ophthalmopathy during cyclosporin treatment.
    Howlett TA; Lawton NF; Fells P; Besser GM
    Lancet; 1984 Nov; 2(8411):1101. PubMed ID: 6150174
    [No Abstract]   [Full Text] [Related]  

  • 14. [Surgical treatment of endocrine ophthalmopathy].
    Rødahl E; Seland J; Olofsson J; Aanderud S; Kråkenes J
    Tidsskr Nor Laegeforen; 1999 May; 119(12):1737-42. PubMed ID: 10380588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of response to transantral orbital decompression in severe Graves' ophthalmopathy.
    Fatourechi V; Bergstralh EJ; Garrity JA; Bartley GB; Beatty CW; Offord KP; Gorman CA
    Mayo Clin Proc; 1994 Sep; 69(9):841-8. PubMed ID: 8065185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of plasma exchange for Graves' ophthalmopathy.
    Kelly W; Longson D; Smithard D; Fawcitt R; Wensley R; Noble J; Keeley J
    Clin Endocrinol (Oxf); 1983 May; 18(5):485-93. PubMed ID: 6688205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graves' ophthalmopathy. An unusual course.
    Khardori R; Weaver ME; Soler NG
    Am J Med; 1984 Dec; 77(6):1121-5. PubMed ID: 6548874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The differential diagnostic problems in unilateral euthyroid Graves' ophthalmopathy.
    Perrild H; Feldt-Rasmussen U; Bech K; Ahlgren P; Hansen JM
    Acta Endocrinol (Copenh); 1984 Aug; 106(4):471-6. PubMed ID: 6548073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sonography of the retrobulbar space in autoimmune hyperthyroidism of the Basedow type].
    Schillings S; Wagner J; Franzen W; Wildmeister W
    Z Gesamte Inn Med; 1990 Nov; 45(22):678-83. PubMed ID: 2099028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.